Biweekly News for Life Science Area! 16/02/2021

The impact of digitalization on food safety

Around the world, legislation related to food safety and quality has become increasingly stringent. In a highly globalized world, a production error can generate problems with reflections in different parts of the planet, from recall actions, financial losses and serious image crises. In addition, the world's population is expected to grow in the coming decades, which will require an additional 70% in food and beverage production, compared to what is produced today.

Government launches guide on packaging for pharmaceutical companies

The Institute of Food Technology (Ital),linked tothe  Department of Agriculture and Supply of the State of São Paulo,has just launched the digital publication Packaging: Basic Guide for the professional of the Pharmaceutical Industry.

International fund acquires drug distributor

The Black Holding investment fund announced the acquisition of MRJ Farma,adistributor specializing in specialty and hospital medicines. The transaction is around R$ 80 million.

AstraZeneca will test anti-Covid vaccine in children and adolescents

The pharmaceutical Company AstraZeneca, which produces an anti-Covid vaccine with the University of Oxford, announced last Saturday (13) that will start clinical studies of the immunizer in people who are between 6 and 17 years.

Sinproquim assesses that end of REIQ will have strong negative impact on the economy

The proposal under study by the economic area of the federal government to extinguish the Special Regime of the Chemical Industry (REIQ) as a way to compensate for the loss of revenue with the reduction of PIS/Cofins on diesel oil is, in sinproquim's opinion, a serious misunderstanding due to the strong negative impacts it would have on the Brazilian economy.

Amazonian biopharmaceuticals for vaccine production

Biopharmaceuticals – The world is experiencing an unprecedented moment of mobilization to confront Covid-19. Governments, powerful pharmaceutical industry groups,and philanthropic institutions contribute billions of dollars to the research and development of vaccines against SARS Cov 2.

Sign up for our fortnightly newsletter!